Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.

Sci Rep · 2015 · PMC4585731 · PMID 26391180

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Metformin showed a trend of improved prognosis of patients receiving gemcitabine One hundred and four patients with diabetes that received gemcitabine treatment after radical resection of pancreatic cancer in Union Hospital, Wuhan, China from Jun 1 st , 2009 to Jun 20 th , 2014 were followed up.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.